When a pain twists the temples in alternating or direct current, one would kill mother and father for a simple aspirin.
We would ruin ourselves for a box of Doliprane, the price of which in pharmacies fixed at 2.18 euros (half the paracetamol in generic version) seems in such a perfectly derisory case.
Putting a price on a drug is an impossible exercise.
It will always seem too expensive at the same time with regard to the stake: to cure.
And never expensive enough for the same reason.
Life is priceless, is it?
However, the health system needs to find the right balance in the complex process of determining the administered price of this particular product.
However, in France, we are very far from the optimum.
The Covid-19 crisis has revealed deficiencies at both ends of the pharmaceutical spectrum.
France was not a breeding ground for messenger RNA technology, which gave the world the first vaccines against the virus.
And she became aware of her addiction to
This article is for subscribers only.
You have 78% left to discover.
Subscribe: 1 € the first month
Cancellable at any time
I ENJOY IT
Already subscribed?
Log in
